z-logo
open-access-imgOpen Access
Repurposing fluvoxamine, and other psychiatric medications, for COVID ‐19 and other conditions
Author(s) -
Lenze Eric J.,
Reiersen Angela M.,
Santosh Paramala J.
Publication year - 2022
Publication title -
world psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.51
H-Index - 93
eISSN - 2051-5545
pISSN - 1723-8617
DOI - 10.1002/wps.20983
Subject(s) - fluvoxamine , medicine , repurposing , placebo , randomized controlled trial , exacerbation , psychiatry , fluoxetine , pharmacology , alternative medicine , ecology , receptor , serotonin , biology , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom